Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 2 |
Alibaba
BABA
|
+$408M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$292M |
| 4 |
Gilead Sciences
GILD
|
+$218M |
| 5 |
Ford
F
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.37B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.18B |
| 3 |
YHOO
Yahoo Inc
YHOO
|
+$619M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Booking.com
BKNG
|
+$406M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.53% |
| 2 | Consumer Discretionary | 2.02% |
| 3 | Financials | 1.63% |
| 4 | Healthcare | 1.38% |
| 5 | Energy | 1.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
PUT
ProShares Ultra NASDAQ Biotechnology
BIB
$105M
| $11.9M | ﹤0.01% |
189,000
-68,000
| -26% | -$3.99M |
|
1827
PRA Group
PRAA
$732M
| $11.8M | ﹤0.01% |
204,527
-27,512
| -12% | -$1.62M |
|
|
ARIA
1828
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $11.8M | ﹤0.01% |
1,723,883
+236,134
| +16% | +$1.48M |
|
1829
PUT
Vanguard Morningstar Total Stock Market ETF
VTI
$685B
| $11.8M | ﹤0.01% |
110,600
+1,100
| +1% | +$114K |
|
1830
PUT
Teradata
TDC
$2.5B
| $11.8M | ﹤0.01% |
270,700
-186,900
| -41% | -$8M |
|
|
NAVB
1831
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $11.8M | ﹤0.01% |
312,495
-1,145
| -0.4% | -$31.5K |
|
1832
CALL
Edwards Lifesciences
EW
$52.5B
| $11.8M | ﹤0.01% |
556,200
+21,000
| +4% | +$422K |
|
1833
Norfolk Southern
NSC
$79.6B
| $11.8M | ﹤0.01% |
107,660
-6,497
| -6% | -$712K |
|
|
CRR
1834
PUT
DELISTED
Carbo Ceramics Inc.
CRR
| $11.8M | ﹤0.01% |
294,000
-205,100
| -41% | -$9.57M |
|
1835
PUT
NRG Energy
NRG
$24.3B
| $11.8M | ﹤0.01% |
436,700
-14,000
| -3% | -$414K |
|
1836
Adobe
ADBE
$108B
| $11.8M | ﹤0.01% |
161,874
+59,106
| +58% | +$4.14M |
|
|
RUSS
1837
PUT
DELISTED
Direxion Daily Russia Bear 3x Shares
RUSS
| $11.8M | ﹤0.01% |
20,920
+11,970
| +134% | +$4.9M |
|
|
OSG
1838
Octave Specialty Group
OSG
$204M
| $11.7M | ﹤0.01% |
478,852
+106,730
| +29% | +$2.49M |
|
1839
PUT
T. Rowe Price
TROW
$23.9B
| $11.7M | ﹤0.01% |
136,200
-132,400
| -49% | -$10.8M |
|
1840
Compass Minerals
CMP
$1.04B
| $11.7M | ﹤0.01% |
134,388
+121,794
| +967% | +$10.4M |
|
1841
PUT
Eastman Chemical
EMN
$8.3B
| $11.6M | ﹤0.01% |
153,400
-22,600
| -13% | -$1.79M |
|
1842
Cigna
CI
$74.7B
| $11.6M | ﹤0.01% |
113,002
-67,823
| -38% | -$6.68M |
|
1843
CALL
Lands' End
LE
$373M
| $11.6M | ﹤0.01% |
215,500
+98,200
| +84% | +$4.63M |
|
1844
CALL
ServiceNow
NOW
$129B
| $11.6M | ﹤0.01% |
856,500
-564,000
| -40% | -$7.18M |
|
|
TRLA
1845
CALL
DELISTED
TRULIA INC (DEL)
TRLA
| $11.6M | ﹤0.01% |
252,500
-137,900
| -35% | -$6.47M |
|
|
CZR
1846
PUT
DELISTED
Caesars Entertainment Corporation
CZR
| $11.6M | ﹤0.01% |
738,800
-13,300
| -2% | -$178K |
|
1847
PUT
Conagra Brands
CAG
$7.76B
| $11.6M | ﹤0.01% |
409,915
-170,006
| -29% | -$4.65M |
|
|
ZNGA
1848
PUT
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $11.6M | ﹤0.01% |
4,349,900
+779,600
| +22% | +$1.97M |
|
|
ULTI
1849
CALL
DELISTED
Ultimate Software Group Inc
ULTI
| $11.6M | ﹤0.01% |
78,800
+51,800
| +192% | +$7.51M |
|
1850
CALL
Allstate
ALL
$66B
| $11.6M | ﹤0.01% |
164,500
-34,700
| -17% | -$2.28M |
|
Similar funds
Jeff Yass's Q4 2014 Portfolio in Review
As of Q4 2014, Jeff Yass held 10,737 positions worth $252B, down 3% from $260B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jeff Yass withdrew a net $10.2B in Q4 2014, closing 1,178 positions and reducing 4,352 holdings. Its most notable exit was Bausch Health, an estimated $68.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2.2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Northern Trust Morningstar Global Upstream Natural Resources ETF worth $31M.
- Jeff Yass's largest Q4 2014 buy was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.22B increase.
- Jeff Yass's biggest Q4 2014 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.37B.
- Jeff Yass fully exited Bausch Health in Q4 2014, selling an estimated $68.9M.
- Jeff Yass's ten largest holdings make up 23% of its $252B portfolio in Q4 2014.
- Jeff Yass opened 1,370 new positions and closed 1,178 in Q4 2014.
- Jeff Yass's portfolio value fell 3% quarter-over-quarter to $252B.
Based on Susquehanna International Group's 13F filing for Q4 2014, filed 17 Feb 2015.